What Factors Are Associated with High-Frequency Drug Treatment Use among a Racially and Ethnically Diverse Population of Injection Drug Users?

REFERENCES

• Hser Y, Huang D, Teruya C, Anglin MD. Diversity of drug abuse treatment utilization patterns and outcomes. Evaluation and Program Planning. 2004;27:309–319.
   Web of Science ®Google Scholar
• McLellan AT, McKay JR, Forman R, Cacciola J, Kemp J. Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring. Addiction. 2005;100:447–458.
   PubMed Web of Science ®Google Scholar
• Lee MT, Reif S, Ritter GA, Levine HJ, Horgan CM. Alcohol and Drug Services Study (ADSS) Phase II: Client record abstract report (DHHS Publication No. SMA04-3974, Analytic Series No A-27). Substance Abuse and Mental Health Services Administration. Available at: http://www.drugabusestatistics.samhsa.gov/ADSS/ADSSclientrecordabsw.pdf. Accessed November 1, 2005.
   Google Scholar
• Anglin DM, Hser YI, Grella CE. Drug addiction and treatment careers among clients in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav. Dec 1997;11:308–323.
   Web of Science ®Google Scholar
• Amodeo M, Chassler D, Ferguson F, Fitzgerald T, Lundgren L. Use of mental health and substance abuse treatment services by female injection drug users. Am J Drug Alcohol Abuse. 2004;30:101–120.
   PubMed Web of Science ®Google Scholar
• Lundgren L, Amodeo M, Ferguson F, Davis K. Racial and ethnic differences in drug treatment entry by injection drug users in Massachusetts: residential treatment versus detoxification only. J Subst Abuse Treat. 2001;21:145–153.
   PubMed Web of Science ®Google Scholar
• Lundgren L, Schilling RF, Ferguson F, Davis K, Amodeo M. Examining drug treatment program entry of injection drug users: human capital and institutional disaffiliation. Evaluation and Program Planning. 2003;26:123–132.
   PubMed Web of Science ®Google Scholar
• Lundgren L, Schilling RF, Sullivan L, Chassler D. Predictors of drug treatment type for women who inject drugs: client characteristics and service access. Unpublished manuscript; 2005.
   Google Scholar
• Lundgren L, Chassler D, Ben-Ami L, Purington T, Schilling RF. Factors associated with emergency use among injection drug users of African American, Hispanic, and white European background. Am J Addict. 2005;14:268–280.
   PubMed Web of Science ®Google Scholar
• Scott CK, Foss M, Dennis M. Pathways in the relapse-treatment-recovery cycle over three years. J Subst Abuse Treat. 2005;28:S63–S72.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration Office of Applied Studies. National Household Survey on Drug Abuse: Main Findings 1998. Rockville, Md.: Substance Abuse and Mental Health Services Administration; 2000.
   Google Scholar
• Zule WA, Desmond DP. Factors predicting entry of injecting drug users into substance abuse treatment. Am J Drug Alcohol Abuse. 2000;26:247–261.
   PubMed Web of Science ®Google Scholar
• Booth RE, Corsi KF, Mikulich-Gilbertson SK. Factors associated with methadone maintenance treatment retention among street-recruited injection drug users. Drug Alcohol Depend. 2004;74:177–185.
   PubMed Web of Science ®Google Scholar
• Luchansky B, He L, Krupski A, Stark KD. Predicting readmission to substance abuse treatment using state information systems: the impact of client and treatment characteristics. J Subst Abuse. 2000;12:255–270.
   PubMedGoogle Scholar
• Weisner C, Matzger H. A prospective study of the factors influencing entry to alcohol and drug treatment. J Behav Health Serv Res. 2002;29:126–137.
   PubMed Web of Science ®Google Scholar
• Schmidt L, Weisner CM. Private insurance and the utilization of chemical dependency treatment. J Subst Abuse Treat. 2005;28:67–76.
   PubMed Web of Science ®Google Scholar
• Shanahan CW, Lincoln A, Horton NJ, Saitz R, Winter M, Samet JH. Relationship of depressive symptoms and mental health functioning to repeat detoxification. J Subst Abuse Treat. 2005;29:117–123.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. Report to Congress on the prevention and treatment of co-occurring substance abuse disorders and mental disorders. Available at: http://alt.samhsa.gov/reports/congress2002/. Cited by: McLellan AT, McKay JR, Forman R, Cacciola J, Kemp J. Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring. Addiction. 2005;100:447–458.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. National survey on substance abuse treatment services (N-SSATS): 2000 data on substance abuse treatment facilities. DHHS publication no. SMA 02-3668. Rockville, Md.: US Government Printing Office; 2002. Cited by: McLellan AT, McKay JR, Forman R, Cacciola J, Kemp J. Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring. Addiction. 2005;100:447–458.
   Google Scholar
• National Institute on Drug Abuse. Principles of drug addiction treatment: a research-based guide. NIH publication no. 00-4180. NIDA. Available at: http://165.112.78.61/PODAT/PODATindex.html. Cited by: McLellan AT, McKay JR, Forman R, Cacciola J, Kemp J. Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring. Addiction. 2005;100:447–458.
   PubMed Web of Science ®Google Scholar
• Hser Y, Grella CE, Hsieh S, Anglin MD, Brown BS. Prior treatment experience related to process and outcomes in DATOS. Drug Alcohol Depend. 1999;57:137–150.
   PubMed Web of Science ®Google Scholar
• Grella CE, Hser Y, Hsieh S. Predictors of drug treatment re-entry following relapse to cocaine use in DATOS. J Subst Abuse Treat. 2003;25:145–154.
   PubMed Web of Science ®Google Scholar
• Cacciola JS, Dugosh K, Foltz C, Leahy P, Stevens R. Treatment outcomes: first time versus treatment-experienced clients. J Subst Abuse Treat. 2005;28:S13–S22.
   PubMed Web of Science ®Google Scholar
• McLellan AT, Lewis DC, O'Brien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA. 2000;284:1689–1695.
   PubMed Web of Science ®Google Scholar
• Lundgren L, Schilling RF, Ferguson F, Amodeo M. Parental status of women injection drug users and entry to methadone maintenance. Subst Use Misuse. 2003;38:1109–1131.
   PubMed Web of Science ®Google Scholar
• McMahon TJ, Winkel JD, Suchman NE, Luthar SS. Drug dependence, parenting responsibilities, and treatment history: why doesn't mom go for help? Drug Alcohol Depend. 2002;65:105–114.
   PubMed Web of Science ®Google Scholar
• Dennis ML, Scott CK, Funk R, Foss MA. The duration and correlates of addiction and treatment careers. J Subst Abuse Treat. 2005;28:S51–S62.
   PubMed Web of Science ®Google Scholar
• McLellan T. Have we evaluated addiction treatment correctly? implications from a chronic care perspective. Addiction. 2002;97:249–252.
   PubMed Web of Science ®Google Scholar
• McCarty D, McGuire TG, Harwood HJ, Field T. Using state information systems for drug abuse services research. American Behavioral Scientist. 1998;41:1090–1106.
   Web of Science ®Google Scholar
• Lundgren LM, Sullivan L, Amodeo M. How do treatment repeaters use the drug treatment system? an analysis of injection drug users in Massachusetts. J Subst Abuse Treat. 2006;30:121–128.
   PubMed Web of Science ®Google Scholar
• Simpson DD. A conceptual framework for drug treatment process and outcomes. J Subst Abuse Treat. 2004;27:99–121.
   PubMed Web of Science ®Google Scholar
• Simpson DD, Joe GW. A longitudinal evaluation of treatment engagement and recovery stages. J Subst Abuse Treat. 2004;27:89–97.
   PubMed Web of Science ®Google Scholar